185 related articles for article (PubMed ID: 35974953)
1. Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Shan Y; Yu X; Yang Y; Sun J; Wu S; Mao S; Lu C
J Hepatocell Carcinoma; 2022; 9():717-728. PubMed ID: 35974953
[TBL] [Abstract][Full Text] [Related]
2.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
[No Abstract] [Full Text] [Related]
4. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma.
Zhu Y; Weng S; Li Y; Yan C; Ye R; Wen L; Zhou L; Gao L
Abdom Radiol (NY); 2021 Jul; 46(7):3139-3148. PubMed ID: 33641018
[TBL] [Abstract][Full Text] [Related]
5. Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma.
Mao S; Yu X; Yang Y; Shan Y; Mugaanyi J; Wu S; Lu C
Sci Rep; 2021 Jul; 11(1):13999. PubMed ID: 34234239
[TBL] [Abstract][Full Text] [Related]
6. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUS.
Luo M; Liu X; Yong J; Ou B; Xu X; Zhao X; Liang M; Zhao Z; Ruan J; Luo B
Eur Radiol; 2023 Jun; 33(6):4024-4033. PubMed ID: 36484835
[TBL] [Abstract][Full Text] [Related]
7. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B
Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520
[TBL] [Abstract][Full Text] [Related]
8. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
9. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract][Full Text] [Related]
10. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.
Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X
J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197
[TBL] [Abstract][Full Text] [Related]
12. Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype.
Yang L; Wang M; Zhu Y; Zhang J; Pan J; Zhao Y; Sun K; Chen F
Front Oncol; 2023; 13():1138848. PubMed ID: 36890813
[TBL] [Abstract][Full Text] [Related]
13. A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy.
He X; Li K; Wei R; Zuo M; Yao W; Zheng Z; He X; Fu Y; Li C; An C; Liu W
Radiol Med; 2023 Dec; 128(12):1508-1520. PubMed ID: 37801197
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study.
He C; Zhang W; Zhao Y; Li J; Wang Y; Yao W; Wang N; Ding W; Wei X; Yang R; Jiang X
Front Oncol; 2023; 13():1124069. PubMed ID: 37197418
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
[TBL] [Abstract][Full Text] [Related]
16. Prediction of macrotrabecular-massive hepatocellular carcinoma by using MR-based models and their prognostic implications.
Chai F; Ma Y; Feng C; Jia X; Cui J; Cheng J; Hong N; Wang Y
Abdom Radiol (NY); 2024 Feb; 49(2):447-457. PubMed ID: 38042762
[TBL] [Abstract][Full Text] [Related]
17. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
18. Tumor metabolism derived from
Hu S; Xie Y; Yang T; Yang Y; Zou Q; Jiao J; Zhang Y
Quant Imaging Med Surg; 2023 Jan; 13(1):309-319. PubMed ID: 36620154
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in Patients with Macrotrabecular-Massive-Subtype Hepatocellular Carcinoma Treated with Yttrium-90 Transarterial Radioembolization.
Balli HT; Piskin FC; Sozutok S; Erdoğan KE; Aikimbaev K
J Vasc Interv Radiol; 2024 Mar; ():. PubMed ID: 38548131
[TBL] [Abstract][Full Text] [Related]
20. Dual-Energy CT Deep Learning Radiomics to Predict Macrotrabecular-Massive Hepatocellular Carcinoma.
Li M; Fan Y; You H; Li C; Luo M; Zhou J; Li A; Zhang L; Yu X; Deng W; Zhou J; Zhang D; Zhang Z; Chen H; Xiao Y; Huang B; Wang J
Radiology; 2023 Aug; 308(2):e230255. PubMed ID: 37606573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]